SCHEMBL9835231

SCHEMBL9835231

CCCCCCC1Nc2cc3c(cc2N1)C(C)(C)C(=O)N3

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ATAD2 Q6PL18 1/20 0.40
PGR P06401 8/20 0.35
PDK2 Q15119 2/20 0.35
PDK4 Q16654 1/20 0.35
PDE3B Q13370 5/20 0.34
PDE3A Q14432 5/20 0.34
PDE4A P27815 4/20 0.34
PDE4B Q07343 4/20 0.34
PDE4C Q08493 4/20 0.34
PDE4D Q08499 4/20 0.34
ALDH1A1 P00352 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PTPN1 P18031 1/20 0.31
ACP1 P24666 1/20 0.31
CDC25B P30305 1/20 0.31
AURKA O14965 1/20 0.31
AURKB Q96GD4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9834909 0.94 ATAD2 (0.42) ATAD2PGRPDK2PDK4PDE3B
SCHEMBL9835356 0.82 ATAD2 (0.46) ATAD2PGRPDK2PDK4PDE3B
SCHEMBL10662924 0.81 ATAD2 (0.40) ATAD2PGRPDK2PDK4PDE3B
SCHEMBL10662906 0.78 KAT2B (0.36) ATAD2PGRPDE3BPDE3APDE4A
SCHEMBL10668135 0.75 ATAD2 (0.43) ATAD2PGRPDK2PDK4PDE3B
SCHEMBL9832960 0.75 ATAD2 (0.38) ATAD2PGRPDK2PDK4PDE3B
SCHEMBL2492338 0.73 PGR (0.42) ATAD2PGRPDK2PDK4PDE3B
SCHEMBL9835271 0.72 ATAD2 (0.43) ATAD2PGRPDK2PDK4PDE3B
SCHEMBL9833546 0.72 ATAD2 (0.38) ATAD2PGRPDK2PDK4PDE3B
SCHEMBL9834623 0.71 ATAD2 (0.42) ATAD2PGRPDK2PDK4PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214592-B1 PYRROLOBENZIMIDAZOLES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE PRODUCTS Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed
US-4730003-A Tricyclic compounds for treating heart and circulatory diseases BOEHRINGER MANNHEIM GMBH (DE) 1988-03-08 US disclosed
EP-0214592-A2 Pyrrolobenzimidazoles, process for their preparation and medicaments containing these products Roche Diagnostics GmbH (DE) 1987-03-18 EP disclosed